Mounjaro 2.5 mg vs Zepbound: Different Approvals, Same Ingredient (Tirzepatide)
Mounjaro 2.5 mg and Zepbound both contain tirzepatide, but they’re approved for different health goals.
Mounjaro is FDA-approved for type 2 diabetes management, helping lower A1C and improve insulin sensitivity. Zepbound, on the other hand, is approved specifically for chronic weight management in adults with obesity or overweight with comorbidities.
Visit : https://buymedlife.com/mounjaro-kwikpen-2-5mg
پسند
تبصرہ
بانٹیں
